Intellia Therapeutics, Inc. short interest in 2022
In 2022, Intellia Therapeutics, Inc.'s disclosed short interest ran from 5.85% of shares outstanding on 14 Jan 2022 to 8.43% on 30 Dec 2022, a change of +2.58 percentage points. The year's high was 9.85% on 30 Jun 2022 and its low 5.85% on 14 Jan 2022, averaging 8.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.78 days on 30 Nov 2022. Full history: Intellia Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 5.85% (14 Jan 2022)
- End of year
- 8.43% (30 Dec 2022)
- Change
- +2.58 pp
- High
- 9.85% (30 Jun 2022)
- Low
- 5.85% (14 Jan 2022)
- Average
- 8.24%
- Highest days to cover
- 9.78 (30 Nov 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 5.85% | 4.19 | results (8-K) |
| 31 Jan 2022 | 6.45% | 3.89 | |
| 15 Feb 2022 | 6.64% | 5.16 | |
| 28 Feb 2022 | 7.12% | 4.70 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 7.22% | 3.21 | |
| 31 Mar 2022 | 7.55% | 5.66 | |
| 14 Apr 2022 | 7.64% | 6.33 | |
| 29 Apr 2022 | 8.23% | 6.80 | |
| 13 May 2022 | 9.16% | 4.61 | 10-Q filed, results (8-K) |
| 31 May 2022 | 8.74% | 7.29 | |
| 15 Jun 2022 | 9.21% | 5.56 | |
| 30 Jun 2022 | 9.85% | 4.17 | |
| 15 Jul 2022 | 9.51% | 5.17 | |
| 29 Jul 2022 | 8.89% | 6.95 | |
| 15 Aug 2022 | 9.17% | 4.93 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 9.04% | 7.65 | |
| 15 Sep 2022 | 8.79% | 5.97 | |
| 30 Sep 2022 | 9.04% | 4.74 | |
| 14 Oct 2022 | 8.66% | 6.93 | |
| 31 Oct 2022 | 8.91% | 7.85 | |
| 15 Nov 2022 | 8.46% | 7.32 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 7.65% | 9.78 | |
| 15 Dec 2022 | 7.56% | 2.99 | |
| 30 Dec 2022 | 8.43% | 5.58 |
See also: Intellia Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.